Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.32-0.20 (-3.62%)
At close: 04:00PM EST
5.20 -0.12 (-2.26%)
After hours: 07:30PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts114911
Avg. Estimate-0.24-0.23-1.05-0.69
Low estimate-0.38-0.34-1.26-1.41
High estimate-0.14-0.11-0.87-0.23
Year ago EPS-0.38-0.28-1.33-1.05
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts1131111
Avg. Estimate89.59M89.15M327.19M400.37M
Low estimate86M87.56M324M326M
High estimate93.31M90.9M331.32M428.96M
Year ago sales79.55M68.78M270.83M327.19M
Sales growth (year/est)12.60%29.60%20.80%22.40%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.17-0.3-0.23-0.23
Actual EPS-0.38-0.28-0.4-0.19
Difference-0.210.02-0.170.04
Surprise %-123.50%6.70%-73.90%17.40%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.24-0.23-1.05-0.69
7 days ago-0.22-0.2-1.03-0.65
30 days ago-0.25-0.17-1.1-0.64
60 days ago-0.25-0.17-1.1-0.62
90 days ago-0.24-0.18-1.08-0.63
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days6275
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.36.80%N/AN/AN/A
Next qtr.17.90%N/AN/AN/A
Current year21.10%N/AN/AN/A
Next year34.30%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A